Can you provide the last earnings date for INNATE PHARMA SA?
INNATE PHARMA SA (IDD.DE) last reported earnings on 3/26/2026.
FRA:IDD • FR0010331421
Past quarterly earnings results for INNATE PHARMA SA (IDD.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | -0.25 | - | - | 1.671M | 4.909M | -65.96% | -79.85% | |
| Q1 2025 | -0.11 | - | - | 4.868M | - | - | ||
| Q4 2024 | - | - | 4.329M | - | -73.85% | |||
| Q2 2024 | - | - | 8.293M | - | -76.54% | |||
| Q4 2023 | - | - | 16.557M | - | 99.27% | |||
| Q2 2023 | - | - | 35.344M | - | -14.36% | |||
| Q4 2022 | - | - | 8.309M | - | 118.20% | |||
| Q2 2022 | - | - | 41.271M | - | 397.00% | |||
| Q4 2021 | - | - | 3.808M | - | -85.53% | |||
| Q2 2021 | - | - | 8.304M | - | -72.17% | |||
| Q4 2020 | -0.08 | - | - | 26.31M | 27.379M | -3.90% | - | |
| Q3 2020 | -0.08 | - | - | 27.379M | - | - | ||
| Q2 2020 | - | - | 29.84M | - | - |
Notes
INNATE PHARMA SA (IDD.DE) last reported earnings on 3/26/2026.
INNATE PHARMA SA (IDD.DE) missed EPS estimates and missed revenue estimates in the most recent quarter.